Related Experiment Video
Updated: May 24, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
[Acquired FX deficiency: a case report and literature review]
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Institutes of Health Science, Tianjin 301600, China.
Abstract:
Objective: To introduce the clinical features, laboratory findings, diagnostic approaches, and treatment of acquired factor X deficiency. Methods: This study reviewed a case of primary light-chain amyloidosis with acquired factor X deficiency admitted to our hospital. The patient's clinical course and diagnostic process were described, and a literature review was conducted. Results: The patient, a 69-year-old male, was admitted to our hospital due to abdominal bleeding. He was diagnosed with primary light-chain amyloidosis complicated by acquired factor X deficiency. Recurrent bleeding was attributed to amyloid deposits in peripheral blood vessels and organs, which adsorbed circulating factor X, causing its sequestration in the reticuloendothelial system (e.g. the spleen) and leading to decreased factor X levels. After active hemostasis and treatment of the underlying disease, the patient was discharged. Conclusion: This case provides insights and a reference for the diagnosis and management of the rare clinical presentation of acquired coagulation factor deficiency.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

